Last reviewed · How we verify
DAT-1604 tablet
At a glance
| Generic name | DAT-1604 tablet |
|---|
| Sponsor | Danatlas Pharmaceuticals Co., Ltd |
|---|
| Modality | Small molecule |
|---|
| Phase | Phase 1 |
|---|
Approved indications
No approved indications tracked.
Common side effects
No common side effects on file.